With the cancer drug market recently having hit US$100 billion, and some industry experts concerned that cancer drug prices are unsustainable, two groups have started working towards calculating the ...
In the midst of physician concerns that Part B drug reimbursements are too low, the Department of Health and Human Services' Office of Inspector General (OIG) is suggesting the Centers for Medicare ...
It costs around US$880 million to bring a new drug to market, even when the price of failure and the cost of capital are included, suggests the latest stab at calculating the cost of drug development.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback